These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30571377)

  • 21. A novel method to enhance phenotype, epicardial functional substrates, and ventricular tachyarrhythmias in Brugada syndrome.
    Chung FP; Raharjo SB; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chao TF; Liao JN; Lin CY; Chang YT; Hung Y; Te A; Yamada S; Tasaka H; Wang CT; Chen SA
    Heart Rhythm; 2017 Apr; 14(4):508-517. PubMed ID: 28065832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrocardiographic and electrophysiologic characteristics in patients with Brugada type electrocardiogram and inducible ventricular fibrillation: single center experience.
    Ohkubo K; Watanabe I; Takagi Y; Okumura Y; Ashino S; Kofune M; Kawauchi K; Yamada T; Kofune T; Hashimoto K; Shindo A; Sugimura H; Nakai T; Saito S; Hirayama A
    Circ J; 2007 Sep; 71(9):1437-41. PubMed ID: 17721024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation.
    Brugada J; Pappone C; Berruezo A; Vicedomini G; Manguso F; Ciconte G; Giannelli L; Santinelli V
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1373-81. PubMed ID: 26291334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of the Brugada-type electrocardiogram and incidence of Brugada syndrome in patients with sick sinus syndrome.
    Hayashi H; Sumiyoshi M; Yasuda M; Komatsu K; Sekita G; Kawano Y; Tokano T; Nakazato Y; Daida H
    Circ J; 2010 Feb; 74(2):271-7. PubMed ID: 20019410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proarrhythmic ECG deterioration caused by myocardial ischemia of the conus branch artery in patients with a Brugada ECG pattern.
    Ogano M; Iwasaki YK; Morita N; Tanabe J; Shiiba K; Miyauchi Y; Kobayashi Y; Tanaka K; Katoh T; Mizuno K
    Pacing Clin Electrophysiol; 2011 Mar; 34(3):e26-9. PubMed ID: 20353416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and Electrocardiographic Differences in Brugada Syndrome With Spontaneous or Drug-Induced Type 1 Electrocardiogram.
    Nagayama T; Nagase S; Kamakura T; Wada M; Ishibashi K; Inoue YY; Miyamoto K; Noda T; Aiba T; Takaki H; Sugimachi M; Shimizu W; Noguchi T; Yasuda S; Kamakura S; Kusano K
    Circ J; 2019 Feb; 83(3):532-539. PubMed ID: 30643106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Utility of Exercise Testing in Risk Stratification of Asymptomatic Patients With Type 1 Brugada Pattern.
    Subramanian M; Prabhu MA; Harikrishnan MS; Shekhar SS; Pai PG; Natarajan K
    J Cardiovasc Electrophysiol; 2017 Jun; 28(6):677-683. PubMed ID: 28316113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term follow-up in patients with Brugada Syndrome in South China.
    Zhao D; Liang B; Peng J; Tang L; Su R; Luo L; Deng B; Wang S
    Ann Noninvasive Electrocardiol; 2021 May; 26(3):e12823. PubMed ID: 33417270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of ventricular arrhythmias in patients with a spontaneous Brugada type 1 pattern: the key is in the electrocardiogram.
    Delinière A; Baranchuk A; Giai J; Bessiere F; Maucort-Boulch D; Defaye P; Marijon E; Le Vavasseur O; Dobreanu D; Scridon A; Da Costa A; Delacrétaz E; Kouakam C; Eschalier R; Extramiana F; Leenhardt A; Burri H; Winum PF; Taieb J; Bouet J; Fauvernier M; Rosianu H; Carabelli A; Duband B; Chevalier P
    Europace; 2019 Sep; 21(9):1400-1409. PubMed ID: 31177270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term prognosis of patients withJ-wave syndrome.
    Kamakura T; Shinohara T; Yodogawa K; Murakoshi N; Morita H; Takahashi N; Inden Y; Shimizu W; Nogami A; Horie M; Aiba T; Kusano K
    Heart; 2020 Feb; 106(4):299-306. PubMed ID: 31391205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights into the location of type I ECG in patients with Brugada syndrome: correlation of ECG and cardiovascular magnetic resonance imaging.
    Veltmann C; Papavassiliu T; Konrad T; Doesch C; Kuschyk J; Streitner F; Haghi D; Michaely HJ; Schoenberg SO; Borggrefe M; Wolpert C; Schimpf R
    Heart Rhythm; 2012 Mar; 9(3):414-21. PubMed ID: 22119454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome.
    Morita H; Kusano KF; Miura D; Nagase S; Nakamura K; Morita ST; Ohe T; Zipes DP; Wu J
    Circulation; 2008 Oct; 118(17):1697-704. PubMed ID: 18838563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of Exercise-Related Ventricular Arrhythmias in Patients With Brugada Syndrome.
    Morita H; Asada ST; Miyamoto M; Morimoto Y; Kimura T; Mizuno T; Nakagawa K; Watanabe A; Nishii N; Ito H
    J Am Heart Assoc; 2020 Dec; 9(23):e016907. PubMed ID: 33222599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A New Electrocardiographic Marker of Sudden Death in Brugada Syndrome: The S-Wave in Lead I.
    Calò L; Giustetto C; Martino A; Sciarra L; Cerrato N; Marziali M; Rauzino J; Carlino G; de Ruvo E; Guerra F; Rebecchi M; Lanzillo C; Anselmino M; Castro A; Turreni F; Penco M; Volpe M; Capucci A; Gaita F
    J Am Coll Cardiol; 2016 Mar; 67(12):1427-1440. PubMed ID: 27012403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic and prognostic value of a type 1 Brugada electrocardiogram at higher (third or second) V1 to V2 recording in men with Brugada syndrome.
    Miyamoto K; Yokokawa M; Tanaka K; Nagai T; Okamura H; Noda T; Satomi K; Suyama K; Kurita T; Aihara N; Kamakura S; Shimizu W
    Am J Cardiol; 2007 Jan; 99(1):53-7. PubMed ID: 17196462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of T-wave alternans during night time as a predictor for ventricular fibrillation in patients with Brugada syndrome.
    Sakamoto S; Takagi M; Tatsumi H; Doi A; Sugioka K; Hanatani A; Yoshiyama M
    Heart Vessels; 2016 Jun; 31(6):947-56. PubMed ID: 25989739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocardial mapping and catheter ablation for ventricular fibrillation prevention in Brugada syndrome.
    Sunsaneewitayakul B; Yao Y; Thamaree S; Zhang S
    J Cardiovasc Electrophysiol; 2012 Nov; 23 Suppl 1():S10-6. PubMed ID: 22988965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tpeak-Tend interval and Tpeak-Tend/QT ratio as markers of ventricular tachycardia inducibility in subjects with Brugada ECG phenotype.
    Letsas KP; Weber R; Astheimer K; Kalusche D; Arentz T
    Europace; 2010 Feb; 12(2):271-4. PubMed ID: 19897501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indication and prognostic significance of programmed ventricular stimulation in asymptomatic patients with Brugada syndrome.
    Asada S; Morita H; Watanabe A; Nakagawa K; Nagase S; Miyamoto M; Morimoto Y; Kawada S; Nishii N; Ito H
    Europace; 2020 Jun; 22(6):972-979. PubMed ID: 32167564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry.
    Priori SG; Gasparini M; Napolitano C; Della Bella P; Ottonelli AG; Sassone B; Giordano U; Pappone C; Mascioli G; Rossetti G; De Nardis R; Colombo M
    J Am Coll Cardiol; 2012 Jan; 59(1):37-45. PubMed ID: 22192666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.